Interferon α and β induce differential transcriptional and functional metabolic phenotypes in human macrophages and blunt glycolysis in response to antigenic stimuli

Gina Leisching,Anjali Yennemadi,Karl Gogan,Joseph Keane
DOI: https://doi.org/10.1002/eji.202451032
2024-07-13
European Journal of Immunology
Abstract:Acute type 1 IFN exposure activates macrophages to induce glycolysis and release proinflammatory mediators, resolving infection. Chronic type 1 IFN exposure, as observed during systemic autoimmune diseases, impairs macrophage glycolytic induction, impairing infection control. IFN‐α2a, α2b, and β induce different metabolic effects in this diseased state. Created with Biorender.com The impact of chronic exposure to type I interferons (IFN)‐α2a, 2b, and β on macrophage metabolism, intimately linked to macrophage function, is not well understood. This study assesses the nuanced host responses induced by type I IFN cytokines, offering insights into potential therapeutic approaches in diseases associated with these cytokines. Employing a combination of transcriptional profiling and real‐time functional analysis, we delineated metabolic reprogramming in response to chronic IFN exposure. Our results reveal distinct transcriptional metabolic profiles between macrophages chronically exposed to IFN‐α and IFN‐β. IFN‐β significantly diminishes the oxygen consumption rate and glycolytic proton extrusion rate in macrophages. Conversely, IFN‐α2b decreased parameters of mitochondrial fitness and induced a shift toward glutamine oxidation. Assessing the ability of macrophages to induce glycolysis in response to antigenic stimuli (LPS and iH37Rv), we found that chronic exposure to all IFN subtypes limited glycolytic induction. This study addresses a critical oversight in the literature, where individual roles of IFN subtypes are frequently amalgamated and lack distinction. These findings not only provide novel insights into the divergent effects of IFN‐α2a, α2b, and β on macrophage metabolism but also highlight their potential implications for developing targeted therapeutic strategies.
immunology
What problem does this paper attempt to address?